Back
Grid Dynamics Holdings- Ordinary Shares - Class A Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
48
GDYN
Grid Dynamics Holdings- Ordinary Shares - Class A
Last Price:
$8.00
Seasonality Move:
7.72%
Buy
57
SRPT
Sarepta Therapeutics
Last Price:
$20.30
Seasonality Move:
8.12%
Sell
48
Grid Dynamics Holdings- Ordinary Shares - Class A (GDYN)
is a Sell
Is Grid Dynamics Holdings- Ordinary Shares - Class A a Buy, Sell or Hold?
-
The current Grid Dynamics Holdings- Ordinary Shares - Class A [GDYN] share price is $8.06. The Score for GDYN is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
GDYN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $20.40. The Score for SRPT is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GDYN Stock Price Chart
What is Grid Dynamics Holdings- Ordinary Shares - Class A's stock price today?
-
The Grid Dynamics Holdings- Ordinary Shares - Class A share price today is $8.06Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GDYN is experiencing slight selling pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $20.40Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
GDYN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.04 | Buy |
Relative Strength Index (14 RSI): | 28.86 | Sell |
Chaikin Money Flow: | -327994 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.27 - 10.83) | Sell |
Bollinger Bands (100): | (10.27 - 14.55) | Sell |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.95 | Buy |
Relative Strength Index (14 RSI): | 57.41 | Buy |
Chaikin Money Flow: | 8584996 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.15 - 19.17) | Buy |
Bollinger Bands (100): | (17.93 - 55.55) | Sell |
GDYN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.92 | Buy |
20-day SMA: | 9.24 | Sell |
50-day SMA: | 10.73 | Sell |
200-day SMA: | 15.97 | Sell |
8-day EMA: | 7.62 | Buy |
20-day EMA: | 5.72 | Buy |
50-day EMA: | 3.16 | Buy |
200-day EMA: | 0.94 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 17.93 | Buy |
20-day SMA: | 16.17 | Buy |
50-day SMA: | 21.34 | Sell |
200-day SMA: | 76.43 | Sell |
8-day EMA: | 17.44 | Buy |
20-day EMA: | 12.42 | Buy |
50-day EMA: | 6.68 | Buy |
200-day EMA: | 1.97 | Buy |
Grid Dynamics Holdings- Ordinary Shares - Class A Earnings Growth & GDYN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.02 per share, an increase this year of $0.03 per share, and an increase next year of $0.11 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.52 per share, an increase next quarter of $1.45 per share, a decrease this year of $5.64 per share, and an increase next year of $5.00 per share.
Grid Dynamics Holdings- Ordinary Shares - Class A Technical Analysis
Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |